Newsroom
October 7, 2022
Researchers from UT Health San Antonio are part of an international team that discovered 61 additional genetic loci associated with stroke and six genes that are potential targets for drug therapy to prevent or treat stroke.
August 23, 2022
UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy (cryo-EM for short). The state-of-the-art technology adds a powerful new tool to solve disease riddles at the molecular level.
June 27, 2022
The Dialysis Doggos are part of a research study being conducted by Meredith L. Stensland, PhD, LMSW, assistant professor of research in the Department of Psychiatry and Behavioral Sciences. The study investigates the effect of an animal assisted intervention for patients receiving dialysis, and if this intervention improves symptoms of pain and depression and reduces the number of skipped dialysis treatment sessions.
June 17, 2022
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
April 27, 2022
The National Institutes of Health has awarded a four-year, $2.4 million grant to The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which will work in collaboration with the American Dental Association Science & Research Institute (ADASRI) to conduct a clinical trial studying the responsible use of antibiotics in combination with other treatments for periodontal disease, commonly known as gum disease.
April 6, 2022
In a breakthrough discovery, scientists at UT Health San Antonio reported that inhibiting a liver enzyme in obese mice decreased the rodents’ appetite, increased energy expenditure in fat tissues and resulted in weight loss.
